Capricor Therapeutics
CAPR
#8014
Rank
NZ$0.50 B
Marketcap
NZ$11.00
Share price
-4.36%
Change (1 day)
-58.66%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are NZ$11.13 Million. In 2024 the company made an earning of -NZ$69.98 Million a decrease over its 2023 earnings that were of -NZ$38.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion100.86%
2024 -NZ$69.98 Million81.57%
2023 -NZ$38.54 Million-23.2%
2022 -NZ$50.19 Million44.93%
2021 -NZ$34.63 Million46.61%
2020 -NZ$23.62 Million78.71%
2019 -NZ$13.22 Million-49.7%
2018 -NZ$26.27 Million-724.78%
2017 NZ$4.2 M-112.93%
2016 -NZ$32.53 Million46.27%
2015 -NZ$22.24 Million106.82%
2014 -NZ$10.75 Million-48.41%
2013 -NZ$20.84 Million977.23%
2012 -NZ$1.94 Million-77.11%
2011 -NZ$8.46 Million-22.35%
2010 -NZ$10.89 Million-20.17%
2009 -NZ$13.64 Million-41.17%
2008 -NZ$23.18 Million41.05%
2007 -NZ$16.43 Million1098.87%
2006 -NZ$1.38 Million4101.55%
2005 -NZ$0.04 Million-0.97%
2004 -NZ$0.04 Million17.87%
2003 -NZ$0.03 Million3.66%
2002 -NZ$0.03 Million-30.11%
2001 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-NZ$1.31 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$8.3 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.01 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.00 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.45 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.41 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA